论文部分内容阅读
三九和赵新先,又一次成为业界和媒体炙手可热的名词。 5月16日下午3时,国资委党委书记李毅中亲临三九集团深圳总部,正式宣布免去三九集团“教父”、掌舵三九近20年的赵新先在三九的所有职务——党委书记、总裁、董事长、首席执行官。 旋即,原中国通用技术集团常务董事、副总经理孙晓民,继任三九集团党委书记、总裁。 赵新先的离职,给本已风雨飘摇的三九今后的经营带来了更多的不确定性。这家中国最大制药企业的未来走向,备受业界关注。
Thirty-nine and Zhao Xinxian once again become a hot topic in the industry and the media. At 15:00 on May 16, Li Yizhong, party secretary of the State-owned Assets Supervision and Administration Commission, personally approached the Sanjiu Group's Shenzhen headquarters to officially announce the removal of the “Godfather” of the Sanjiu Group and the appointment of Zhao Xinxian, President, Chairman and Chief Executive Officer. Soon, the former General Manager of China General Technology Group, Sun Xiaomin, deputy general manager, succeeded Sanjiu Group Secretary of the party committee, president. The departure of Zhao Xinxian has brought more uncertainty to the already precarious operation of March Nine. The future direction of China's largest pharmaceutical company has drawn the attention of the industry.